Advertisement
Screener

PACIRA BIOSCIENCES, INC. (PCRX) Investment Income, Interest

2.0 / 5 stars · 29/74 Roast Me

PACIRA BIOSCIENCES, INC. Investment Income, Interest

PACIRA BIOSCIENCES, INC. (PCRX) reported Investment Income, Interest of $1.94 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Income Statement › Other Income

us-gaap:InvestmentIncomeInterest · last filed 2026-08-04

  • PACIRA BIOSCIENCES, INC. investment income, interest for the quarter ending 2026-06-30 was $1.94M, a 61.18% decline year-over-year.
  • PACIRA BIOSCIENCES, INC. investment income, interest for the quarter ending 2026-03-31 was $1.93M, a 72.01% decline year-over-year.
  • PACIRA BIOSCIENCES, INC. investment income, interest for the quarter ending 2025-12-31 was $2.29M, a 58.69% decline year-over-year.
  • PACIRA BIOSCIENCES, INC. investment income, interest for the quarter ending 2025-09-30 was $8.53M, a 55.67% increase year-over-year.
  • PACIRA BIOSCIENCES, INC. investment income, interest for fiscal 2025 was $22.73M, a 15.46% increase from fiscal 2024.
  • PACIRA BIOSCIENCES, INC. investment income, interest for fiscal 2024 was $19.69M, a 72.05% increase from fiscal 2023.
  • PACIRA BIOSCIENCES, INC. investment income, interest for fiscal 2023 was $11.44M, a 151.96% increase from fiscal 2022.
  • PACIRA BIOSCIENCES, INC. investment income, interest for fiscal 2022 was $4.54M, a 406.92% increase from fiscal 2021.
Period endInvestment Income, Interest 3 monthInvestment Income, Interest 6 monthInvestment Income, Interest 9 monthInvestment Income, Interest 12 month
2026-06-30$1.94M
10-Q · filed 2026-08-04
$3.87M
10-Q · filed 2026-08-04
$6.17M
derived: sum of 3 quarters · filed 2026-08-04
$14.70M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31$1.93M
10-Q · filed 2026-04-30
$4.22M
derived: sum of 2 quarters · filed 2026-04-30
$12.76M
derived: sum of 3 quarters · filed 2026-04-30
$17.77M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31$2.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$10.83M
derived: sum of 2 quarters · filed 2026-02-26
$15.84M
derived: sum of 3 quarters · filed 2026-08-04
$22.73M
10-K · filed 2026-02-26
2025-09-30$8.53M
10-Q · filed 2025-11-06
$13.54M
derived: sum of 2 quarters · filed 2026-08-04
$20.44M
10-Q · filed 2025-11-06
$25.99M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30$5.01M
10-Q · filed 2026-08-04
$11.90M
10-Q · filed 2026-08-04
$17.46M
derived: sum of 3 quarters · filed 2026-08-04
$22.94M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31$6.89M
10-Q · filed 2026-04-30
$12.45M
derived: sum of 2 quarters · filed 2026-04-30
$17.93M
derived: sum of 3 quarters · filed 2026-04-30
$22.68M
derived: sum of 4 quarters · filed 2026-04-30
2024-12-31$5.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$11.04M
derived: sum of 2 quarters · filed 2026-02-26
$15.79M
derived: sum of 3 quarters · filed 2026-02-26
$19.69M
10-K · filed 2026-02-26
2024-09-30$5.48M
10-Q · filed 2025-11-06
$10.23M
derived: sum of 2 quarters · filed 2025-11-06
$14.13M
10-Q · filed 2025-11-06
$17.56M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$4.75M
10-Q · filed 2025-08-05
$8.65M
10-Q · filed 2025-08-05
$12.08M
derived: sum of 3 quarters · filed 2026-02-26
$14.84M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$3.90M
10-Q · filed 2025-05-08
$7.33M
derived: sum of 2 quarters · filed 2026-02-26
$10.09M
derived: sum of 3 quarters · filed 2026-02-26
$12.21M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$3.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$6.19M
derived: sum of 2 quarters · filed 2026-02-26
$8.30M
derived: sum of 3 quarters · filed 2026-02-26
$11.44M
10-K · filed 2026-02-26
2023-09-30$2.77M
10-Q · filed 2024-11-06
$4.88M
derived: sum of 2 quarters · filed 2024-11-06
$8.02M
10-Q · filed 2024-11-06
$10.80M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30$2.11M
10-Q · filed 2024-07-30
$5.25M
10-Q · filed 2024-07-30
$8.04M
derived: sum of 3 quarters · filed 2025-02-27
$9.27M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31$3.14M
10-Q · filed 2024-05-07
$5.93M
derived: sum of 2 quarters · filed 2025-02-27
$7.16M
derived: sum of 3 quarters · filed 2025-02-27
$7.41M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31$2.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$4.02M
derived: sum of 2 quarters · filed 2025-02-27
$4.27M
derived: sum of 3 quarters · filed 2025-02-27
$4.54M
10-K · filed 2025-02-27
2022-09-30$1.23M
10-Q · filed 2023-11-02
$1.49M
derived: sum of 2 quarters · filed 2023-11-02
$1.76M
10-Q · filed 2023-11-02
$1.84M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$252.00K
10-Q · filed 2023-08-02
$523.00K
10-Q · filed 2023-08-02
$603.00K
derived: sum of 3 quarters · filed 2024-02-29
$780.00K
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31$271.00K
10-Q · filed 2023-05-03
$351.00K
derived: sum of 2 quarters · filed 2024-02-29
$528.00K
derived: sum of 3 quarters · filed 2024-02-29
$752.00K
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31$80.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$257.00K
derived: sum of 2 quarters · filed 2024-02-29
$481.00K
derived: sum of 3 quarters · filed 2024-02-29
$896.00K
10-K · filed 2024-02-29
2021-09-30$177.00K
10-Q · filed 2022-11-03
$401.00K
derived: sum of 2 quarters · filed 2022-11-03
$816.00K
10-Q · filed 2022-11-03
$1.51M
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30$224.00K
10-Q · filed 2022-08-03
$639.00K
10-Q · filed 2022-08-03
$1.33M
derived: sum of 3 quarters · filed 2023-02-28
$2.36M
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31$415.00K
10-Q · filed 2022-05-04
$1.11M
derived: sum of 2 quarters · filed 2023-02-28
$2.13M
derived: sum of 3 quarters · filed 2023-02-28
$3.46M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31$693.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$1.72M
derived: sum of 2 quarters · filed 2023-02-28
$3.04M
derived: sum of 3 quarters · filed 2023-02-28
$4.63M
10-K · filed 2023-02-28
2020-09-30$1.02M
10-Q · filed 2021-11-03
$2.35M
derived: sum of 2 quarters · filed 2021-11-03
$3.94M
10-Q · filed 2021-11-03
$5.60M
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30$1.32M
10-Q · filed 2021-08-03
$2.91M
10-Q · filed 2021-08-03
$4.58M
derived: sum of 3 quarters · filed 2022-02-28
$6.32M
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31$1.59M
10-Q · filed 2021-05-04
$3.26M
derived: sum of 2 quarters · filed 2022-02-28
$4.99M
derived: sum of 3 quarters · filed 2022-02-28
$6.81M
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31$1.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
$3.40M
derived: sum of 2 quarters · filed 2022-02-28
$5.22M
derived: sum of 3 quarters · filed 2022-02-28
$7.38M
10-K · filed 2022-02-28
2019-09-30$1.74M
10-Q · filed 2020-10-30
$3.55M
derived: sum of 2 quarters · filed 2020-10-30
$5.71M
10-Q · filed 2020-10-30
$7.71M
derived: sum of 4 quarters · filed 2021-03-01
2019-06-30$1.82M
10-Q · filed 2020-08-06
$3.97M
10-Q · filed 2020-08-06
$5.98M
derived: sum of 3 quarters · filed 2021-03-01
$7.56M
derived: sum of 4 quarters · filed 2021-03-01
2019-03-31$2.16M
10-Q · filed 2020-05-07
$4.16M
derived: sum of 2 quarters · filed 2021-03-01
$5.75M
derived: sum of 3 quarters · filed 2021-03-01
$7.28M
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
$3.59M
derived: sum of 2 quarters · filed 2021-03-01
$5.12M
derived: sum of 3 quarters · filed 2021-03-01
$6.50M
10-K · filed 2021-03-01
2018-09-30$1.59M
10-Q · filed 2019-11-08
$3.12M
derived: sum of 2 quarters · filed 2019-11-08
$4.49M
10-Q · filed 2019-11-08
$5.77M
derived: sum of 4 quarters · filed 2020-02-21
2018-06-30$1.53M
10-Q · filed 2019-08-08
$2.91M
10-Q · filed 2019-08-08
$4.18M
derived: sum of 3 quarters · filed 2020-02-21
$5.25M
derived: sum of 4 quarters · filed 2020-02-21
2018-03-31$1.37M
10-Q · filed 2019-05-02
$2.65M
derived: sum of 2 quarters · filed 2020-02-21
$3.71M
derived: sum of 3 quarters · filed 2020-02-21
$4.94M
derived: sum of 4 quarters · filed 2020-02-21
2017-12-31$1.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21
$2.34M
derived: sum of 2 quarters · filed 2020-02-21
$3.56M
derived: sum of 3 quarters · filed 2020-02-21
$4.08M
10-K · filed 2020-02-21
2017-09-30$1.07M
10-Q · filed 2018-11-01
$2.29M
derived: sum of 2 quarters · filed 2018-11-01
$2.81M
10-Q · filed 2018-11-01
$3.21M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30$1.22M
10-Q · filed 2018-08-02
$1.74M
10-Q · filed 2018-08-02
$2.14M
derived: sum of 3 quarters · filed 2019-02-28
$2.48M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31$514.00K
10-Q · filed 2018-05-03
$914.00K
derived: sum of 2 quarters · filed 2019-02-28
$1.26M
derived: sum of 3 quarters · filed 2019-02-28
$1.58M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31$400.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$746.00K
derived: sum of 2 quarters · filed 2019-02-28
$1.07M
derived: sum of 3 quarters · filed 2019-02-28
$1.32M
10-K · filed 2019-02-28
2016-09-30$346.00K
10-Q · filed 2017-11-08
$670.00K
derived: sum of 2 quarters · filed 2017-11-08
$923.00K
10-Q · filed 2017-11-08
$1.10M
derived: sum of 4 quarters · filed 2018-02-28
2016-06-30$324.00K
10-Q · filed 2017-08-02
$576.00K
10-Q · filed 2017-08-02
$750.00K
derived: sum of 3 quarters · filed 2018-02-28
$921.00K
derived: sum of 4 quarters · filed 2018-02-28
2016-03-31$252.00K
10-Q · filed 2017-05-04
$426.00K
derived: sum of 2 quarters · filed 2018-02-28
$597.00K
derived: sum of 3 quarters · filed 2018-02-28
$774.00K
derived: sum of 4 quarters · filed 2018-02-28
2015-12-31$174.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28
$345.00K
derived: sum of 2 quarters · filed 2018-02-28
$522.00K
derived: sum of 3 quarters · filed 2018-02-28
$678.00K
10-K · filed 2018-02-28
2015-09-30$171.00K
10-Q · filed 2016-11-02
$348.00K
derived: sum of 2 quarters · filed 2016-11-02
$504.00K
10-Q · filed 2016-11-02
$885.00K
derived: sum of 4 quarters · filed 2017-03-01
2015-06-30$177.00K
10-Q · filed 2016-08-04
$332.00K
10-Q · filed 2016-08-04
$714.00K
derived: sum of 3 quarters · filed 2017-03-01
$848.00K
derived: sum of 4 quarters · filed 2017-03-01
2015-03-31$155.00K
10-Q · filed 2016-05-02
$537.00K
derived: sum of 2 quarters · filed 2017-03-01
$671.00K
derived: sum of 3 quarters · filed 2017-03-01
$732.00K
derived: sum of 4 quarters · filed 2017-03-01
2014-12-31$382.00K
10-K · filed 2017-03-01
$516.00K
derived: sum of 2 quarters · filed 2017-03-01
$577.00K
derived: sum of 3 quarters · filed 2017-03-01
$382.00K
10-K · filed 2016-02-25
2014-09-30$134.00K
10-Q · filed 2015-10-27
$195.00K
derived: sum of 2 quarters · filed 2015-10-27
$237.00K
10-Q · filed 2015-10-27
$289.00K
derived: sum of 4 quarters · filed 2016-02-25
2014-06-30$61.00K
10-Q · filed 2015-07-30
$103.00K
10-Q · filed 2015-07-30
$155.00K
derived: sum of 3 quarters · filed 2016-02-25
$217.00K
derived: sum of 4 quarters · filed 2016-02-25
2014-03-31$42.00K
10-Q · filed 2015-04-30
$94.00K
derived: sum of 2 quarters · filed 2016-02-25
$156.00K
derived: sum of 3 quarters · filed 2016-02-25
$228.00K
derived: sum of 4 quarters · filed 2016-02-25
2013-12-31$52.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25
$114.00K
derived: sum of 2 quarters · filed 2016-02-25
$186.00K
derived: sum of 3 quarters · filed 2016-02-25
$259.00K
10-K · filed 2016-02-25
2013-09-30$62.00K
10-Q · filed 2014-10-30
$134.00K
derived: sum of 2 quarters · filed 2014-10-30
$207.00K
10-Q · filed 2014-10-30
$264.00K
derived: sum of 4 quarters · filed 2015-02-24
2013-06-30$72.00K
10-Q · filed 2014-07-31
$145.00K
10-Q · filed 2014-07-31
$202.00K
derived: sum of 3 quarters · filed 2015-02-24
$289.00K
derived: sum of 4 quarters · filed 2015-02-24
2013-03-31$73.00K
10-Q · filed 2014-05-01
$130.00K
derived: sum of 2 quarters · filed 2015-02-24
$217.00K
derived: sum of 3 quarters · filed 2015-02-24
$285.00K
derived: sum of 4 quarters · filed 2015-02-24
2012-12-31$57.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24
$144.00K
derived: sum of 2 quarters · filed 2015-02-24
$212.00K
derived: sum of 3 quarters · filed 2015-02-24
$275.00K
10-K · filed 2015-02-24
2012-09-30$87.00K
10-Q · filed 2013-10-31
$155.00K
derived: sum of 2 quarters · filed 2013-10-31
$218.00K
10-Q · filed 2013-10-31
$362.00K
derived: sum of 4 quarters · filed 2014-02-25
2012-06-30$68.00K
10-Q · filed 2013-08-06
$131.00K
10-Q · filed 2013-08-06
$275.00K
derived: sum of 3 quarters · filed 2014-02-25
$321.00K
derived: sum of 4 quarters · filed 2014-02-25
2012-03-31$63.00K
10-Q · filed 2013-05-08
$207.00K
derived: sum of 2 quarters · filed 2014-02-25
$253.00K
derived: sum of 3 quarters · filed 2014-02-25
$290.00K
derived: sum of 4 quarters · filed 2014-02-25
2011-12-31$144.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$190.00K
derived: sum of 2 quarters · filed 2014-02-25
$227.00K
derived: sum of 3 quarters · filed 2014-02-25
$255.00K
10-K · filed 2014-02-25
2011-09-30$46.00K
10-Q · filed 2012-11-01
$83.00K
derived: sum of 2 quarters · filed 2012-11-01
$111.00K
10-Q · filed 2012-11-01
$146.00K
derived: sum of 4 quarters · filed 2013-03-07
2011-06-30$37.00K
10-Q · filed 2012-08-09
$65.00K
10-Q · filed 2012-08-09
$100.00K
derived: sum of 3 quarters · filed 2013-03-07
$139.00K
derived: sum of 4 quarters · filed 2013-03-07
2011-03-31$29.00K
10-Q · filed 2012-05-09
$63.00K
derived: sum of 2 quarters · filed 2013-03-07
$102.00K
derived: sum of 3 quarters · filed 2013-03-07
$140.00K
derived: sum of 4 quarters · filed 2013-03-07
2010-12-31$34.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07
$73.00K
derived: sum of 2 quarters · filed 2013-03-07
$111.00K
derived: sum of 3 quarters · filed 2013-03-07
$146.00K
10-K · filed 2013-03-07
2010-09-30$39.00K
10-Q · filed 2011-10-31
$77.00K
derived: sum of 2 quarters · filed 2011-10-31
$112.00K
10-Q · filed 2011-10-31
2010-06-30$38.00K
10-Q · filed 2011-08-11
$73.00K
10-Q · filed 2011-08-11
2009-12-31$77.00K
10-K · filed 2012-03-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Savara Inc (SVRA)United States$1.044B-9.10
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
MANNKIND CORP (MNKD)United States$1.058B-30.41
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Arbutus Biopharma Corp (ABUS)$0.965B6.19
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
Amphastar Pharmaceuticals, Inc. (AMPH)United States$1.116B10.93